オリゴデンドロサイト前駆細胞の制御機構および病態時の機能に関する研究

1.

Waxman SG et al., Relative conduction velocities of small myelinated and non-myelinated

fibres in the central nervous system. Nat New Biol. 238:217–219 (1972)

2.

Lee Y et al., Oligodendroglia metabolically support axons and contribute to neurodegeneration.

Nature. 487:443–448 (2012)

3.

Frohman EM et al., Multiple sclerosis—the plaque and its pathogenesis. N Engl J Med.

354:942–955 (2006)

4.

Fornari E et al., Demyelination of superficial white matter in early Alzheimer’s disease: a

magnetization transfer imaging study. Neurobiol Aging. 428: e7–19. (2012)

5.

Najjar S et al., Neuroinflammation and white matter pathology in schizophrenia: systematic

review. Schizophr Res.161:102–112 (2016)

6.

Cui QL et al., Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis. Am

J Pathol. 183:516–525 (2013)

7.

Sypecka J et al., The neuroprotective effect exerted by oligodendroglial progenitors on

ischemically impaired hippocampal cells. Mol Neurobiol. 49:685–701 (2014)

8.

Chen LX et al., Neuroprotective effects of oligodendrocyte progenitor cell transplantation in

premature rat brain following hypoxic-ischemic injury. PLoS One. 10:e0115997 (2015)

9.

Faulkner J et al., Human embryonic stem cell-derived oligodendrocyte progenitors for the

treatment of spinal cord injury. Transpl Immunol. 15:131–142 (2005)

10. Kuroda M et al., Peripherally derived FGF21 promotes remyelination in the central nervous

system. J Clin Invest. 127:3496–3509 (2017)

11. Ferent J et al., Sonic Hedgehog signaling is a positive oligodendrocyte regulator during

demyelination. J Neurosci. 33:1759–1772 (2013)

12. Ortega F et al., Oligodendrogliogenic and neurogenic adult subependymal zone neural stem

cells constitute distinct lineages and exhibit differential responsiveness to Wnt signalling. Nat

Cell Biol. 15:602–613 (2013)

13. Li C et al., A functional role of NMDA receptor in regulating the differentiation of

oligodendrocyte precursor cells and remyelination. Glia. 61:732–749 (2013)

14. BaronW et al., PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of

proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci.

15:314–329 (2000)

15. Lundgaard I et al., Neuregulin and BDNF induce a switch to NMDA receptor-dependent

myelination by oligodendrocytes. PLoS Biol. 11:e1001743 (2013)

16. Fannon J et al., Neuronal activity and AMPA-type glutamate receptor activation regulates the

morphological development of oligodendrocyte precursor cells. Glia. 63:1021–1035 (2015)

47

17. Hamilton N et al., Axons and astrocytes release ATP and glutamate to evoke calcium signals in

NG2-glia. Glia. 58:66–79 (2010)

18. Cheli VT et al., Voltage-gated Ca2+ entry promotes oligodendrocyte progenitor cell maturation

and myelination in vitro. Exp Neurol. 265:69–83 (2015)

19. Paez PM et al., Multiple kinase pathways regulate voltage-dependent Ca2+ influx and migration

in oligodendrocyte precursor cells. J Neurosci. 30:6422–6433 (2010)

20. Wu LJ et al., International Union of Basic and Clinical Pharmacology. LXXVI. Current

progress in the mammalian TRP ion channel family. Pharmacol Rev. 62:381–404 (2010)

21. Paez PM et al., Modulation of canonical transient receptor potential channel 1 in the

proliferation of oligodendrocyte precursor cells by the golli products of the myelin basic protein

gene. J Neurosci. 31:3625–3637 (2011)

22. Hoffmann A et al., TRPM3 is expressed in sphingosine-responsive myelinating

oligodendrocytes. J Neurochem. 114:654–665 (2010)

23. Hamilton NB et al., Proton-gated Ca(2+)-permeable TRP channels damage myelin in

conditions mimicking ischaemia. Nature. 529:523–527 (2016)

24. Shibasaki K et al., Effects of body temperature on neural activity in the hippocampus:

regulation of resting membrane potentials by transient receptor potential vanilloid 4. J Neurosci.

27:1566–1575 (2007)

25. Shibasaki K et al., Expression of the basic helix-loop-factor Olig2 in the developing retina:

Olig2 as a new marker for retinal progenitors and late-born cells. Gene Expr Patterns. 7:57–65

(2007)

26. Ma J et al., An animal model for late onset chronic demyelination disease caused by failed

terminal differentiation of oligodendrocytes. Neuron Glia Biol. 2:81–91 (2006)

27. Ma J et al., Induced expression of cathepsins and cystatin C in a murine model of

demyelination. Neurochem Res. 32:311–320 (2007)

28. Shirakawa H et al., Sphingosine-1-phosphate induces Ca2+ signaling and CXCL1 release via

TRPC6 channel in astrocytes. Glia. 65:1005–1016 (2017)

29. Miyake T et al., Cold sensitivity of TRPA1 is unveiled by the prolyl hydroxylation blockadeinduced sensitization to ROS. Nat Commun. 7:12840 (2016)

30. Konno M et al., Stimulation of transient receptor potential vanilloid 4 channel suppresses

abnormal activation of microglia induced by lipopolysaccharide. Glia. 60:761–770 (2012)

31. Shibasaki K et al., A novel subtype of astrocytes expressing TRPV4 (transient receptor

potential vanilloid 4) regulates neuronal excitability via release of gliotransmitters. J Biol Chem.

289:14470–14480 (2014)

32. Alpizar

YA et

al.,

TRPV4

activation

triggers

protective

responses

lipopolysaccharides in airway epithelial cells. Nat Commun. 8:1059 (2017)

48

to

bacterial

33. Watanabe H et al., Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate

TRPV4 channels. Nature. 424:434–438 (2003)

34. Zheng F et al., Plasma metabolomics profiles in rats with acute traumatic brain injury. PLoS

One. 12:e0182025 (2017)

35. McTigue DM et al., Proliferation of NG2-positive cells and altered oligodendrocyte numbers in

the contused rat spinal cord. J Neurosci. 21:3392–3400 (2001)

36. Mochizuki T et al., The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP

release in primary urothelial cell cultures. J Biol Chem. 287:21257–21264 (2009)

37. Jahan MGS et al., Traction force and its regulation during cytokinesis in Dictyostelium cells.

Eur J Cell Biol. 96:515–528 (2017)

38. Pathak MM et al., Stretch-activated ion channel Piezo1 directs lineage choice in human neural

stem cells. Proc Natl Acad Sci U S A. 111:16148–16153 (2014)

39. Chun SJ et al., Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell

spreading and CNS myelination. J Cell Biol. 163:397–408 (2003)

40. Alessandri-Haber N et al., Interaction of transient receptor potential vanilloid 4, integrin, and

SRC tyrosine kinase in mechanical hyperalgesia. J Neurosci. 28:1046–1057 (2008)

41. Kiyatkin EA et al., Brain temperature fluctuation: a reflection of functional neural activation.

Eur J Neurosci. 16:164–168 (2002)

42. Fekete Z et al., Simultaneous in vivo recording of local brain temperature and

electrophysiological signals with a novel neural probe. J Neural Eng. 14:034001 (2017)

43. Cheli VT et al., Conditional deletion of the L-type calcium channel Cav1.2 in oligodendrocyte

progenitor cells affects postnatal myelination in mice. J Neurosci. 36:10853–10869 (2016)

44. Paez PM et al., Golli myelin basic proteins stimulate oligodendrocyte progenitor cell

proliferation and differentiation in remyelinating adult mouse brain. Glia. 60:1078–1093 (2012)

45. Bhat NR et al., Cell proliferation and protooncogene induction in oligodendroglial progenitors.

J Neurosci Res. 32:340–349 (1992)

46. Radhakrishna M et al., Protein kinases mediate basic fibroblast growth factor’s stimulation of

proliferation and c-fos induction in oligodendrocyte progenitors. Mol Brain Res. 24:118–128

(1994)

47. Dimou L et al., NG2-glia and their functions in the central nervous system. Glia. 63:1429–1451

(2015)

48. Iijima K et al., Transplanted microvascular endothelial cells promote oligodendrocyte precursor

cell survival in ischemic demyelinating lesions. J Neurochem. 135:539–550 (2015)

49. Xu S et al., Glial cells: role of the immune response in ischemic stroke. Front Immunol. 11:294

(2020)

50. Seo JH et al., Oligodendrocyte precursors induce early blood–brain barrier opening after white

49

matter injury. J Clin Invest.123:782–786 (2013)

51. Harlow DE et al., Myelin proteolipid protein complexes with αv integrin and AMPA receptors

in vivo and regulates AMPA-dependent oligodendrocyte progenitor cell migration through the

modulation of cell-surface GluR2 expression. J Neurosci. 35:12018–12032 (2015)

52. Kougioumtzidou E et al., Signalling through AMPA receptors on oligodendrocyte precursors

promotes myelination by enhancing oligodendrocyte survival. eLife. 6:e28080 (2017)

53. Santiago González DA et al., Conditional deletion of the L-type calcium channel cav1.2 in

NG2-positive cells impairs remyelination in mice. J Neurosci. 37:10038–10051 (2017)

54. Pitman KA et al., The voltage-gated calcium channel CaV1.2 promotes adult oligodendrocyte

progenitor cell survival in the mouse corpus callosum but not motor cortex. Glia. 68:376–392

(2020)

55. Papanikolaou M et al., Lewis A, Butt AM. Store-operated calcium entry is essential for glial

calcium signalling in CNS white matter. Brain Struct Funct. 222:2993–3005 (2017)

56. Wagner TF et al., Transient receptor potential M3 channels are ionotropic steroid receptors in

pancreatic β cells. Nat Cell Biol. 10:1421–1430 (2008)

57. Grimm C et al., Activation of the melastatin-related cation channel TRPM3 by D-erythrosphingosine. Mol Pharmacol. 67:798–805 (2005)

58. Grimm C et al., Kraft R, Sauerbruch S, Schultz G, Harteneck C. Molecular and functional

characterization of the melastatin-related cation channel TRPM3. J Biol Chem. 278:21493–

21501 (2003)

59. Son A et al., TRPM3/TRPV4 regulates Ca2+-mediated RANKL/NFATc1 expression in

osteoblasts. J Mol Endocrinol. 61:207–218 (2018)

60. Vriens J et al., TRPM3 is a nociceptor channel involved in the detection of noxious heat.

Neuron. 70:482–494 (2011)

61. Held K et al., TRPM3 in temperature sensing and beyond. Temperature (Austin). 2:201–213

(2015)

62. Fonfria E et al., Tissue distribution profiles of the human TRPM cation channel family. J

Recept Signal Transduct Res. 26:159–178 (2006)

63. Zamudio-Bulcock PA et al., Pregnenolone sulfate increases glutamate release at neonatal

climbing fiber-to-Purkinje cell synapses. Neuroscience. 175:24–36 (2011)

64. Zamudio-Bulcock PA et al., Activation of steroid-sensitive TRPM3 channels potentiates

glutamatergic transmission at cerebellar Purkinje neurons from developing rats. J Neurochem.

119:474–485 (2011)

65. Puentes S et al., Brain microvascular endothelial cell transplantation ameliorates ischemic

white matter damage. Brain Res. 1469:43–53 (2012)

66. Sheehan D et al., Theory and practice of histotechnology, second ed., The CV Mosby Company,

50

St. Louis, pp. 235–237 (1980)

67. Straub I et al., Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo.

Mol Pharmacol. 84:736–750 (2013)

68. Hayakawa K et al., Vascular endothelial growth factor regulates the migration of

oligodendrocyte precursor cells. J Neurosci. 31:10666–10670 (2011)

69. Tokumoto Y et al., Quiescence of adult oligodendrocyte precursor cells requires thyroid

hormone and hypoxia to activate Runx1. Sci Rep. 7:1019 (2017)

70. Meletti S et al., Decreased allopregnanolone levels in cerebrospinal fluid obtained during status

epilepticus. Epilepsia. 58:e16–e20 (2017)

71. Nilius B et al., A TRP channel-steroid marriage. Nat Cell Biol.10:1383–1384 (2008)

72. Bičíková M et al., Serum concentrations of some neuroactive steroids in women suffering from

mixed anxiety-depressive disorder. Neurochem Res. 25:1623–1627 (2000)

73. Tagawa N et al., Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and

pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clin

Chem. 46:523–528 (2000)

74. Schumacher M et al., Pregnenolone sulfate in the brain: a controversial neurosteroid.

Neurochem Int. 52:522–540 (2008)

75. Zwain IH et al., Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral

cortex of rat brain. Endocrinology. 140:3843–3852 (1999)

76. Salman ED et al., Hydroxysteroid sulfotransferase 2B1b expression and localization in normal

human brain. Horm Mol Biol Clin Investig. 8:445–454 (2011)

77. Chudakova DA et al., Integrin-associated Lyn kinase promotes cell survival by suppressing acid

sphingomyelinase activity. J Biol Chem. 283:28806–28816 (2008)

78. Badheka D et al., Inhibition of transient receptor potential melastatin 3 ion channels by Gprotein βγ subunits. eLife. 6:e26147 (2017)

79. Quallo T et al., G protein βγ subunits inhibit TRPM3 ion channels in sensory neurons. eLife.

6:e26138 (2017)

80. Shimauchi-Ohtaki H et al., The dynamics of revascularization after white matter infarction

monitored in Flt1-tdsRed and Flk1-GFP mice. Neurosci Lett. 692:70–76 (2019)

81. Kimura I et al., Oligodendrocytes upregulate blood–brain barrier function through mechanisms

other than the PDGF-BB/PDGFRα pathway in the barrier-tightening effect of oligodendrocyte

progenitor cells. Neurosci Lett. 715:134594 (2020)

82. Ono H et al., Rat white matter injury model induced by endothelin-1 injection: technical

modification and pathological evaluation. Acta Neurobiol Exp (Wars). 76:212–224 (2016)

83. Kirby L et al., Oligodendrocyte precursor cells present antigen and are cytotoxic targets in

inflammatory demyelination. Nat Commun. 10:3887 (2019)

51

84. Evonuk KS et al., Reduction of AMPA receptor activity on mature oligodendrocytes attenuates

loss of myelinated axons in autoimmune neuroinflammation. Sci Adv. 6:eaax5936 (2020)

85. Dong Y et al., When encephalitogenic T cells collaborate with microglia in multiple sclerosis.

Nat Rev Neurol. 15:704-717 (2019)

86. Planas R et al., Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis

Brain Lesions. Front Immunol. 9:509 (2018)

87. Fünfschilling U et al., Glycolytic oligodendrocytes maintain myelin and long-term axonal

integrity. Nature. 485:517–521 (2012)

88. Yeung MS et al., Dynamics of oligodendrocyte generation and myelination in the human brain.

Cell. 159:766–774 (2014)

89. Yeung MSY et al., Dynamics of oligodendrocyte generation in multiple sclerosis. Nature.

566:538–542 (2019)

90. Falcão AM et al., Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat

Med. 24:1837–1844 (2018)

91. Jäkel S et al., Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature.

566:543–547 (2019)

92. Barres BA et al., Cell death and control of cell survival in the oligodendrocyte lineage. Cell.

70:31–46 (1992)

93. Miyamura S et al., Oligodendrocyte Glycoprotein 35-55 (MOG 35-55)-induced Experimental

Autoimmune Encephalomyelitis: A Model of Chronic Multiple Sclerosis. Bio Protoc. 9:e3453

(2019)

94. M. Tsutsui et al., TRPM2 Exacerbates Central Nervous System Inflammation in Experimental

Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines. J Neurosci.

38:8484–8495 (2018)

95. Dorrier CE et al., CNS fibroblasts form a fibrotic scar in response to immune cell infiltration.

Nat Neurosci. 24:234–244 (2021)

96. Yahn S et al., Fibrotic scar after experimental autoimmune encephalomyelitis inhibits

oligodendrocyte differentiation. Neurobiol Dis.134:104674 (2020)

97. Maki T, Novel roles of oligodendrocyte precursor cells in the developing and damaged brain.

Clin Exp Neuroimmunol. 8:33–42 (2017)

98. Niu J et al., Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier,

triggering CNS inflammation. Nat Neurosci. 22:709–718 (2019)

99. Kawakami N et al., The activation status of neuroantigen-specific T cells in the target organ

determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med. 199:185–197

(2004)

100. Zveik O et al., Cerebrospinal fluid of progressive multiple sclerosis patients reduces

52

differentiation and immune functions of oligodendrocyte progenitor cells. Glia. 70, 1191–1209

(2022)

101. Monaghan KL et al., Monocytes and Monocyte-Derived Antigen-Presenting Cells Have

Distinct Gene Signatures in Experimental Model of Multiple Sclerosis. Front Immunol. 10:2779

(2019)

102. Yamasaki R et al., Differential roles of microglia and monocytes in the inflamed central

nervous system. J Exp Med. 211:1533–1549 (2014)

103. Rivers LE et al., PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform

projection neurons in adult mice. Nat Neurosci. 11:1392–1401 (2008)

104. Kuhlmann T et al., Differentiation block of oligodendroglial progenitor cells as a cause for

remyelination failure in chronic multiple sclerosis. Brain. 131:1749–1758 (2008)

105. Wang J et al., Targeting Microglia and Macrophages: A Potential Treatment Strategy for

Multiple Sclerosis. Front Pharmacol. 10:286 (2019)

106. Wolf Y et al., Microglial MHC class II is dispensable for experimental autoimmune

encephalomyelitis and cuprizone-induced demyelination. Eur J Immunol. 48:1308–1318 (2018)

107. Mundt S et al., Conventional DCs sample and present myelin antigens in the healthy CNS and

allow parenchymal T cell entry to initiate neuroinflammation. Sci Immunol. 4:eaau8380 (2019)

108. Buxadé M et al., Macrophage-specific MHCII expression is regulated by a remote Ciita

enhancer controlled by NFAT5. J Exp Med. 215:2901–2918 (2018)

109. Lee N et al., Role of NFAT5 in the Immune System and Pathogenesis of Autoimmune Diseases.

Front Immunol. 10:270 (2019)

110. Hayakawa K et al., CD200 restrains macrophage attack on oligodendrocyte precursors via tolllike receptor 4 downregulation. J Cereb Blood Flow Metab. 36:781–793 (2016)

111. Moyon S et al., Demyelination causes adult CNS progenitors to revert to an immature state and

express immune cues that support their migration. J Neurosci. 35:4–20 (2015)

112. Zeis T et al., The immunomodulatory oligodendrocyte. Brain Res. 1641:139–148 (2016)

113. Choi S et al., Transcription factor NFAT5 promotes macrophage survival in rheumatoid arthritis.

J Clin Invest. 127:954–969 (2017)

114. Moreno MA et al., Therapeutic depletion of monocyte-derived cells protects from long-term

axonal loss in experimental autoimmune encephalomyelitis. J Neuroimmunol. 290:36–46

(2016)

115. Mishra MK et al., Myeloid cells - targets of medication in multiple sclerosis. Nat Rev Neurol.

12:539–551 (2016)

116. Nally FK et al., Nanomodulation of Macrophages in Multiple Sclerosis. Cells. 8:543 (2019)

117. Girolamo F et al., Defining the role of NG2-expressing cells in experimental models of multiple

sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.

53

PLoS One. 14:e0213508 (2019)

118. Moransard M et al., NG2 expressed by macrophages and oligodendrocyte precursor cells is

dispensable in experimental autoimmune encephalomyelitis. Brain. 134:1315–1330 (2011)

54

...